Madrigal Statement on the Passing of Dr. Stephen Harrison
April 24 2024 - 4:00PM
The Madrigal team is shocked and saddened to learn of the passing
of Dr. Stephen Harrison.
We offer our deepest condolences to Stephen’s family for their
loss.
Stephen was a colleague and friend to so many of us at Madrigal.
He worked tirelessly to improve the lives of people with
nonalcoholic steatohepatitis (NASH), and his contributions to the
field will touch countless families across the globe for decades to
come. So many of the recent innovations and achievements we’ve seen
in NASH research stemmed from his constant collaboration with
partners in academia, industry, the regulatory sciences, and the
patient community.
Stephen was much more than a brilliant investigator and
physician; he was a true leader who inspired all of us with his
commitment to patients. We’ll remember his sense of humor, his
courtesy, and his boundless energy and optimism.
The field of hepatology has lost a true giant.
Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Nov 2023 to Nov 2024